Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies, with a poor long-term prognosis, and effective therapeutic options are lacking. Observing the dynamics of the pathogenesis of pancreatic intraepithelial neoplasia (PanIN) and PDAC in tumor models can facilitate understanding of the molecular mechanisms involved in early PDAC. Furthermore, it can compensate for the research limitations associated with analyzing clinical specimens of late-stage PDAC. In this study, we orthotopically treated the pancreas with dimethylbenzanthracene (DMBA) combined with caerulein in wild-type C57BL/6 J mice to induce inflammation-related pancreatic carcinogenesis. We observed that DMBA and caerulein treatment induced a chronic consumptive disease, which caused a decrease in the relative body and pancreas weights, diminishing the health status of the mice and enhancing the inflammation-related histological changes. Moreover, mid-dose and high-frequency treatment with caerulein caused prolonged inflammatory damage to the pancreas and contributed to a permissive environment for the development of PDAC. CXCL12/CXCR4, CCL2/CCR2, and several cytokines, such as interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α were upregulated in the tumor tissue of DMBA and caerulein-induced PDAC mice. This orthotopic mouse pancreatic carcinogenesis model mimic human disease because it reproduces a spectrum of pathological changes observed in human PDAC, ranging from inflammatory lesions to pancreatic intraepithelial neoplasia. Thus, this mouse model may improve the understanding of molecular mechanisms underlying the injuryinflammation-cancer pathway in the early stages of pancreatic carcinogenesis.
Introduction
Pancreatic cancer is one of the most deadly human malignant neoplasms and is the fourth leading cause of cancer deaths in the United States [1] . Most patients with pancreatic cancer are often diagnosed at an advanced stage, when distant metastases are evident and it is difficult to perform surgical resection or irradiation. Moreover, high resistance to conventional chemotherapy and radiotherapy further worsens the prognosis. Although several chemotherapy regimens have recently been developed for advanced pancreatic cancer, the results are not satisfactory, with a median survival period of <1 year [2] . Pancreatic ductal adenocarcinoma (PDAC) is the major histological type of pancreatic cancer, accounting for >80 % of human pancreatic neoplasms [3] . Studies have shown that activating K-ras mutations are present in 30 % of pancreatic intraepithelial neoplasias (PanINs), increasing to 100 % in advanced PDACs, which commonly develop from PanINs [4] .
Epidemiologically, infection and chronic inflammation contribute to approximately one in four cancer cases [5] , including pancreatic cancer. Chronic pancreatitis has been identified as a risk factor for the development of PDAC in humans [6] . It has been shown to markedly accelerate the development of PanIN and PDAC in Kras-driven mouse models of PDAC [7] . Moreover, a significantly lower incidence of pancreatic cancer has been noted in patients treated for chronic pancreatitis with surgical resection [8] . Interestingly, an analysis of patient samples and genetically engineered models (GEMs) suggests that chronic pancreatitis and PDAC have several common mediators that regulate both the inflammatory and oncogenic pathways involved in desmoplasia and inflammatory infiltrates. These observations indicate that overlapping mechanisms of inflammatory responses likely link chronic inflammation of the pancreas to the increased risk of cancer [9] .
The progression from initial pancreatic injury to PDAC is a multi-factorial phenomenon involving a series of events. However, the PanIN transformation process that occurs in the pancreatic epithelium is a key initial step in the development and progression of PDAC. Recent studies have revealed that recurrent pancreatic injury-triggered inflammation induces acinar cells to begin the process of acinar-to-ductal metaplasia (ADM) via reprogramming to a pre-neoplastic state, followed by the development of PanIN and PDAC [7, 10, 11] .
To date, the obstacles to developing more effective treatments for human pancreatic cancer have primarily been the lack of understanding of pancreatic tumorigenesis and poor tools for its early detection. Thus, a model is needed with better induction of inflammation-related pancreatic carcinogenesis with few limitations and that is representative of the genetic and histological alterations in respective human tumors. Dimethylbenzanthracene (DMBA), a carcinogen used to reproduce human PDAC with mutated K-ras [12] , has been widely administered to establish an orthotopic model of pancreatic cancer [13] [14] [15] . Caerulein is a cholecystokinin analog that induces the secretion of pancreatic enzymes to cause pancreatic inflammatory injury [7] .
In the present study, we administered combined DMBA and repeated caerulein treatment to establish a mouse model of inflammation-related pancreatic cancer. This led to a faithful reproduction of the progressive histological changes responsible for the progression from chronic pancreatitis to PDAC in humans. This mouse model will enable the identification of target molecules that are crucially involved in the growth of pancreatic cancer cells, which can be used in early screening and the development of therapeutics.
Materials and methods

Chemicals
DMBA and caerulein were purchased from Sigma Chemical Co. (St. Louis, MO, USA). DMBA was prepared as a 2.5 % solution in toluene, and caerulein was prepared as a 0.4 g/L stock solution in physiological saline. The caerulein stock solution was subsequently diluted to a final concentration of 0.04 g/L immediately before use. All reagents used were of analytical grade.
Induction of inflammation-related orthotopic pancreatic carcinogenesis
Forty pathogen-free female wild-type (WT) C57BL/6 J mice (6-8 weeks old) weighing 17-18 g were obtained from the Shanghai Medical College of Fudan University and housed in standard animal cages under specific pathogen-free conditions in the animal facility at the college in Shanghai, China. The mice were randomly divided into four groups: the blank control group (BC group), negative control group (NC group), chronic intensive-treatment group (CIT group), and chronic moderate-treatment group (CMT group). Before experimentation began, the mice were allowed to acclimate for 1 week. The day before surgery, they were fasted for 18 h, and skin preparations were performed with depilatory paste to reduce the rate of postoperative infection. Subsequently, the mice were anesthetized by injecting 2 % pentobarbital sodium (Sigma, St. Louis, MO, USA) into the abdominal cavity. After making a 5-to 10-mm transverse incision on the left flank of the mouse through the skin and peritoneum, the tail of the pancreas was exposed. For the NC, CIT, and CMT groups, 1 mg of DMBA dissolved in toluene was injected into the pancreatic tail to form a saccule (Fig. 1a-c ). The pancreas with the saccule was returned into the abdomen, and the incision was subsequently closed. The BC group was injected with toluene instead of DMBA. One week after DMBA administration, the animals in the CIT and CMT groups were intraperitoneally injected with caerulein dissolved in physiological saline twice daily at 1 h intervals. The mice in the CMT group were treated with caerulein at 100 μg/kg 3 days weekly for 10 weeks, while the mice in the CIT group were treated at 200 μg/kg 2 days weekly for 13 weeks, as previously described [16] . The mice in the NC and BC groups were not administered caerulein. Nineteen weeks after the first injection of caerulein, all of the mice were narcotized using ether and sacrificed by cervical dislocation (Fig. 1d) 
Macropathological observation
During the course of the experiment, the animals were monitored every day, and the whole-body weight was measured twice a week. The relative growth rate of body weight was calculated by increased body weight relative to the body weight of the mice prior to surgery. After the pancreases were removed at the end of the experiment, their weights were determined, and the pancreatic weight/body weight ratios were calculated.
The sizes of the tumors were measured using a caliper, and the tumor volumes were calculated as follows:
Other macroscopic scores for each group of mice were calculated based on grading the scoring criteria on a scale from 0 to 2, as shown in Table 1 , and the score of each group was the average score for all of the analyzed mice in the group.
3.0-Tesla magnetic resonance imaging examinations
For magnetic resonance imaging (MRI) experiments, mice were anesthetized with 2 % pentobarbital sodium. Thereafter, the mice were maintained in a supine position. A 3.0-Tesla MRI for small animals (MAGNETOM Verio, Siemens, Erlangen, Germany) was performed using a whole mouse body coil with T1-SE and T2-TSE sequences. The whole-body coil was a volume coil that allowed imaging the whole mouse without inducing any inhomogeneities in the signals. To determine the size of the tumors, we used highresolution T2-weighted images (T2-WI) in the coronal and horizontal planes. The acquisition parameters were as follows: for T1-weighted images (T1-WI), repetition time ( 
Histological analysis
The paraffin-embedded pancreas tissues were serially cut into 4-μm sections and then stained using a hematoxylin and eosin (H&E) solution. Criteria were selected to establish a novel histological system to quantify the severity of the PanIN lesions and pancreatitis based on previously described standards [10, 17, 18] . Briefly, the score for each pancreas was calculated based on grading the scoring criteria on a scale from 0 to 3 ( Table 2 ). The score for each mouse was the average score for 5 randomly chosen fields from one slide, and the score for each group was the average score for all of the analyzed mice in the group. A pathologist blinded to the treatment protocol scored all of the cases upon histological evaluation.
RNA isolation and quantitative real-time PCR
Total RNA was isolated from part of the pancreas tissue using TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) and subsequently reverse transcribed into complementary DNA (cDNA) using a PrimeScript RT Reagent Kit (Takara Biotechnology Co., Ltd., Dalian, China) according to the manufacturer's instructions. Real-time PCR was performed using an Applied Biosystems HT7900 PCR system with SYBR® Premix Ex Taq™ II, ROX Reference Dye (Takara Biotechnology Co., Ltd., Dalian, China), primers (10 μM), and 50 ng of cDNA in a 10-μl reaction mixture. The relative expression of chemokines and cytokines was analyzed through the ΔΔCT comparative threshold method. GAPDH was used as an internal control. Messenger RNA (mRNA) levels were expressed relative to mRNA levels in the negative control (NC) group.
Statistical analysis
A χ2 test or Fisher's exact test was used to compare the weight loss and macropathological indices of the four groups. Other data are expressed as the means±SEM and were analyzed using a one-way ANOVA. p values of <0.05 (*) and <0.01 (**) were considered statistically significant. The statistical analysis was performed using GraphPad Prism statistical software (GraphPad Prism Version 5.0c).
Results
Induction of orthotopic pancreatic carcinogenesis through dimethylbenzanthracene and caerulein treatment
In our study, combined treatment with DMBA and caerulein resulted in the development of PDAC. Following treatment, five mice died (12.5 %) and were excluded, and 35 mice were included for subsequent analysis. Twenty percent (2/10) of the mice in the CIT group and 20 % (2/10) of the mice in the CMT group were lost, whereas no animals (0 %) in the BC group and 10 % (1/10) of the mice in the NC group were lost. Upon autopsy, the deceased mice (died 17-18 weeks after the first injection of caerulein) exhibited certain pathological complications, such as duodenal/stomach obstruction or bloody ascites, and the dead mice in the CMT group had developed tumors. No significant differences in between-group losses were observed (p=0.4727, χ 2 test). The earliest appearance of tumors by palpation in the CIT and CMT groups was 16 and 15 weeks after the first injection of caerulein, respectively. Nineteen weeks after caerulein treatment, six mice in the CMT group and one mouse in the CIT group had developed tumors, whereas no tumors developed in the NC and BC groups (Fig. 1e) . Furthermore, the tumor volume in the CMT group was 101.7±155.2 mm 3 , whereas that of the CIT group was 12.5 mm 3 (Fig. 1f) .
Decrease in relative body weight and pancreas weight by dimethylbenzanthracene and caerulein treatment
The body weights of all mice in the four groups remained stable at approximately 25 g throughout several weeks of treatment ( Fig. 2a-e) , whereas the rate of weight increase of the CMT group was relatively slow during the early period of caerulein administration and then increased linearly after the cessation of caerulein treatment (Fig. 2d, e) . However, this changing trend of body weight was not observed in the CIT group, in which the relative growth rate of body weight was nearly linear from when caerulein treatment began to the end of the observational period (Fig. 2c, e) . Interestingly, the relative growth rate of body weight was significantly lower in the caerulein treatment groups compared with the BC group, whereas DMBA treatment alone did not lead to decreased weight during a short period (Fig. 2f) . At the end of the experiment, the pancreatic weight/body weight ratio was significantly lower in mice in the NC and CIT groups compared with the BC group, whereas it was higher in the CMT group (Figs. 2g and 3a) .
Caerulein-induced chronic consumptive disease contributes to pancreatic cancer generation via dimethylbenzanthracene treatment
During the course of the experiment, we carefully observed changes in macroscopic indicators ( Table 1 ). The coats of the mice in the treatment groups were mostly dull, and their fur frequently fell off. Concomitantly, the mice in the treatment groups had poor mobility and exhibited lassitude, whereas most mice in the control groups had more vigor. Moreover, some mice in the CIT and CMT groups produced semi-solid or loose stools. The CMT group developed several complications, including bloody ascites and advanced gastroesophageal obstruction (Fig. 3B) . Compared with the control groups, the treatment groups included more mice that developed splenatrophy and extensive adhesions on abdominal organs. Most macroscopic indicators contributed to assessing the health status of the mice and revealed significant differences (Table 1 and Fig. 3C ). We also performed MRI imaging to monitor the growth of orthotopic tumors. The MRI results showed that five mice in the CMT group and one mouse in the CIT group developed tumors (Fig. 3D-g ). The size of the tumors in the CMT group mice was much greater than that of the CIT group (Fig. 3F, G) . MRI scans clearly revealed the tumors, which exhibited inhomogeneous isointensity on T1-WI (Fig. 3G-b) and hyperintensity on T2-WI (Fig. 3G-a and G-c) , as well as the spleens, which were enveloped by tumor tissues (Fig. 3G-a) . However, the MRI did not detect liver or lung metastases. Moreover, several mice in the CMT group developed ascites and gastroesophageal obstruction. More mice in the treatment groups had splenic atrophy compared with those in the control groups (Fig. 3G-c) . However, the mice without tumors primarily displayed the imaging features of pancreatitis, which appears as pancreatic atrophy, in which less obvious MRI-signal changes lead to the disappearance of the normal contour and the presence of a blurred pancreatic border (Fig. 3F-a and F-c) . In addition, pancreatic pseudocysts, which showed high signal intensity in T2-WI, were observed in some of mice (data not shown).
Enhanced inflammation-related histological changes and chemokine and cytokine gene expression in CMT mice
Next, we examined the histological features of the pancreases of the mice. Compared with the BC group, the NC group had sporadic ductal hyperplasia (Fig. 4a-d) . The histological changes in the CIT group primarily consisted of ADM, lowgrade PanIN lesions, and mild inflammatory responses (Fig. 4e, f) , whereas high-grade PanIN lesions, PDAC, and severe inflammatory responses were observed in the CMT group (Fig. 4g, h) . Notably, the histological changes in the pancreases of the CMT mice were significantly greater than those of the CIT and control groups, including acinar-cell vacuolation and focal necrosis (Fig. 4i) , interstitial edema with inflammatory cell infiltration (Fig. 4j) , extensive stromal fibrosis (Fig. 4k) , multi-focal loss of acinar cells (Fig. 4l, m) , widened lobular space and remarkable atrophy (Fig. 4n) , and infiltration of red blood cells (Fig. 4o) , as well as a higher frequency of high-grade PanIN lesions and PDAC (Fig. 4g) . Moreover, tumor formation was confirmed histologically as highly differentiated adenocarcinoma, and no liver or lung metastases were observed. Next, we utilized the abovedescribed scoring system (Table 2 ) to quantify the severity of the PanIN lesions and pancreatitis. As shown in Fig. 4p , the CMT group had a significantly higher score than the other three groups, although the CIT group also had a high score compared with the NC group. In addition, the expression of CXCL12/CXCR4 and CCL2/CCR2 axis genes, but not CXCL3/CXCR2 axis genes, was significantly upregulated in the CIT and CMT groups compared to the NC group (Fig. 5a-f ). The universally acknowledged inflammatory factors interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α, but not IL-1α, also exhibited increased expression (Fig. 5g-j) .
Discussion
An optimal tumor model reproduces many features of the human tumor at the molecular and tissue levels, as well as its biological properties, and contributes to fully translating knowledge gathered from preclinical studies to the clinic. To date, the major types of animal models for studying pancreatic cancer are implantation models, chemical-induction models, and GEMs. Implantation models have been widely employed in preclinical studies in recent years [19, 20] . However, xenografts trapped by connective tissue can only grow locally and exhibit limited invasiveness and metastasis. Moreover, the architecture and microenvironment of these tumors are not identical to those of human tumors, which include inflammatory cells, vasculature, and other stromal components [21, 22] . GEMs involving the conditional activation of the endogenous K-ras oncogene are the only mouse models that have faithfully reproduced the progressive histological changes responsible for human PDAC [23] . However, the high establishment cost, long establishment period, and low productive efficiency are bottlenecks for its extensive application in investigations of tumorigenesis. Finally, carcinogens can activate oncogenes or inactivate cancer-suppressor genes, leading to various different tumors. The pathogenesis in the orthotopic induction model has the strongest resemblance to the natural process of pancreatic cancer development and may represent a series of the initiating events of PDAC.
In this study, we successfully established the mouse PDAC model by treating mice with a combination of DMBA and caerulein. In one study, 9 months after the rat pancreas was injected with DMBA, visible pancreatic cancer had been induced [24] . Moreover, several reports have described an association between pancreatic cancer, alcohol consumption, and exposure to tobacco smoke, as well as a higher relative frequency of DMBA-induced PDAC in mice administered alcohol [25] [26] [27] . However, only indirect epidemiological evidence exists to demonstrate that the consumption of alcohol increases the risk of pancreatitis [28] . On the contrary, we observed that mice treated with DMBA and chronic moderate caerulein had a higher frequency of tumor formation and that their tumors developed more rapidly and were larger. The Several studies have demonstrated that chronic inflammation facilitates tumorigenesis in DMBA-induced PDAC [25, 26, 29] . Caerulein was commonly used in models to cause chronic pancreatitis. The determining hyperstimulatory factor in promoting the development of PDAC was the frequency of caerulein treatment and not the intensity of the dose in the tested ranges [30, 31] . Several lines of evidence indicate that maximal pancreatic injury occurs by 12 h and resolves spontaneously by 24-48 h after the start of caerulein treatment [32, 33] . However, when K-ras is mutated, the ability to regenerate the pancreas is compromised, and the injured cells are maintained in persistent ADM that can rapidly give rise to PanINs [10, 34] (Fig. 6a) .
Indeed, in the present study, most pancreases of mice treated with high-dose and low-frequency caerulein (CIT mice) appeared to be in the restoration stage, and the effects of the inflammatory attack were less obvious after repeated injections. However, pancreatic injury was aggravated by the mid-dose and high-frequency caerulein injection regimen (CMT mice), suggesting that injured tissues were more sensitive to caerulein than undamaged tissues. Thus, tumor formation in the CMT mice occurred more rapidly than in the CIT mice. These observations indicate that one high-dose treatment with caerulein may enhance the induction of acute pancreatitis, whereas high-frequency treatment causes prolonged inflammatory damage of the pancreas and contributes to the generation of an environment permissive to PDAC development. Notably, murine tolerance due to hyperstimulation may also be a lethal factor. Thus, the schedule used in treating the CMT group may better mimic the inflammatory environment to develop pancreatic cancer in an in vivo mouse model.
The potent carcinogen DMBA promotes pancreatic genetic alterations and can result in the injury, necrosis, and fibrosis of pancreatic tissue, causing pancreatic weight loss. However, the process of induction is sufficiently long that pancreatic exocrine functions can compensate for these changes; thus, body weight in the NC group was not decreased. Caerulein accelerates the injurious effect of DMBA, which may block the regeneration of acinar cells following acute pancreatitis, leading to the loss of acini and pancreatic atrophy that gradually gives rise to ADM and PanINs. A combination of DMBA and caerulein injured the pancreas, resulting in the slow increase of body weight and relative pancreatic weight loss. Pancreatic injury resulted in exocrine pancreatic insufficiency, which was the major cause of a slow increase of body weight [35] . Pancreatic weight was used as a simple marker of chronic active pancreatitis, which reflected the degree of pancreatic atrophy after chronic injury [36, 37] . However, in the CMT group, the pancreas weights did not decrease because of tumor formation. In addition, the fecal character of the mice in the CMT and CIT groups may suggest the development of diarrhea or exocrine insufficiency. Some reports have shown that splenic atrophy may be involved in pancreatitis injury [38] . In line with this finding, we observed that the spleens of the treated mice had significantly shrunk. Moreover, the expression of several chemokine and cytokine genes was increased in mice in the CIT and CMT groups. These observations indicate that caerulein was effective in inducing the formation of an inflammatory microenvironment in the pancreas of our model, and these chemokines were also involved in the development of tumors, as reported previously [39] [40] [41] . Thus, inflammatory microenvironments are conducive to the initiation of pancreatic cancer. In addition, our macroscopic scores only represented the differences between the control groups and the treatment groups, and it was difficult to distinguish between the NC and BC groups and CMT and CIT groups. However, histological scores, which could distinguish the CMT group from the CIT group, are more accurate inflammatory indicators and tumor-related indicators than macroscopic scores.
Recurrent pancreatic injuries produce a pro-inflammatory microenvironment, resulting in chronic pancreatitis. The early changes in pancreatitis-related genes within pancreatic tissue lead to the production of cytokines that initiate a chain of events that results in tumor formation, growth, and metastasis [42] [43] [44] . Cells that have sustained DNA damage utilize this prolonged inflammatory response to alter the microenvironment, eventually leading to damaged cells being locked in a persistently dedifferentiated state that can rapidly give rise to PanINs [10, 34, 45] . There is an overlap in the pathogenesis of chronic pancreatitis and PDAC at both the genetic and microenvironmental levels. Caerulein treatment of mutant K-ras mice resulted in a faster development of high-grade PanIN lesions and PDAC [7] , indicating that chronic inflammatory injury may provoke genetic changes that render cells more sensitive to DMBA. In turn, cells with K-ras mutations are particularly vulnerable to further injury in the inflammatory microenvironment [46, 47] . This phenomenon creates a strong positive-feedback loop that accelerates and strengthens DMBA-induced carcinogenesis when combined with the effect of inflammation in promoting cancer, resulting in inflammation-related PDAC (Fig. 6b) .
Conclusion
Taken together, these results indicate the successful establishment of a novel and effective mouse model via the regimen used in the CMT group. This model simulates high-risk patients who have a history of exposure to carcinogenic factors and chronic pancreatitis, and it reproduces the early stage of human PDAC, which will facilitate our understanding of the molecular factors involved in inflammation-related PDAC. This model also enriches the research tools available for investigating the relationship between PDAC and inflammation and will be useful in identifying molecular targets for early diagnosis and treatment.
